99 results
8-K
ALNY
Alnylam Pharmaceuticals Inc
20 Jan 12
Results of Operations and Financial Condition
12:00am
its overall workforce by approximately 33%, to approximately 115 employees, as it aligns its resources to focus on what the Company believes to be its … . The Company expects to substantially complete the workforce reduction by the end of the first quarter of 2012.
Item 9.01. Financial Statements
8-K
ALNY
Alnylam Pharmaceuticals Inc
24 Sep 10
Cost Associated with Exit or Disposal Activities
12:00am
restructuring pursuant to which it will reduce its overall workforce by approximately 25% to 30%. The Company expects this reduction in personnel costs … . The Company expects to substantially complete the workforce reduction by the end of the fourth quarter of 2010.
Item 5.02.
Departure of Directors
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
20 Jan 12
Results of Operations and Financial Condition
12:00am
workforce, as it aligns its resources to focus on what it believes to be the company’s highest value opportunities with accelerated clinical … an approximate 33% reduction in our workforce,” said John Maraganore, Ph.D., Chief Executive Officer of Alnylam. “At a personal level, this was a very difficult
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
3 May 12
Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results
12:00am
and compensation and related expenses also decreased due primarily to the reduction in workforce in connection with our January 2012 strategic corporate … . This financing, combined with our recent corporate restructuring that included an approximate 33% reduction in workforce, results in a balance sheet
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
9 Feb 12
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
this year to implement a strategic corporate restructuring that included an approximate 33% reduction in our workforce. We believe we will finish 2012 … . In January 2012, Alnylam announced a strategic corporate restructuring, including an approximate 33% reduction in its workforce. The workforce
8-K
EX-99.1
lbbzf4u vl0k
14 Jan 13
Other Events
12:00am
8-K
EX-99.1
dc2xtfhfwfzqm3pl
3 Nov 10
Alnylam Pharmaceuticals Reports Third Quarter 2010 Financial Results
12:00am
8-K
EX-99.1
rhns4zx2edst6uy
6 Aug 12
Alnylam Pharmaceuticals Reports Second Quarter 2012 Financial Results
12:00am
424B5
hzoy36xaepn0n663 1s
13 Feb 12
Prospectus supplement for primary offering
12:00am
424B5
tcl 2ddw2
15 Feb 12
Prospectus supplement for primary offering
12:00am
424B5
fzy4ipexbok
14 Jan 13
Prospectus supplement for primary offering
12:00am
424B5
g7ob r3bphowg75bj8o
16 Jan 13
Prospectus supplement for primary offering
12:00am